Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria


Vollbach, Kristina, Schuetz, Catharina, Hedrich, Christian M ORCID: 0000-0002-1295-6179, Speth, Fabian, Moenkemoeller, Kirsten, Brunner, Juergen, Neudorf, Ulrich, Rietschel, Christoph, Hospach, Anton, Kallinich, Tilmann et al (show 11 more authors) (2022) Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists and Nephrologists in Germany and Austria. FRONTIERS IN PEDIATRICS, 10. 851998-.

[img] PDF
Working Towards a Treat-to-Target Protocol in Juvenile Proliferative Lupus Nephritis - A Survey of Pediatric Rheumatologists.pdf - Published version
Download (527kB) | Preview

Abstract

<h4>Background</h4>To describe treatment practices for juvenile proliferative lupus nephritis (LN) class III and IV of pediatric rheumatologists and nephrologists in Germany and Austria in preparation for a treat-to-target treatment protocol in LN.<h4>Methods</h4>Survey study by members of the Society for Pediatric and Adolescent Rheumatology (GKJR) and the German Society for Pediatric Nephrology (GPN) on diagnostics and (concomitant) therapy of LN.<h4>Results</h4>Fifty-eight physicians completed the survey. Overall, there was a considerable heterogeneity regarding the suggested diagnostics and management of juvenile proliferative LN. Increased urinary protein excretion, either assessed by 24 h urine collection or spot urine (protein-creatinine ratio), and reduced estimated glomerular filtration rate were specified as important parameters for indication of kidney biopsy to diagnose proliferative LN and monitoring of therapy. Corticosteroids were generally proposed for induction and maintenance therapy, most often in conjunction with either mycophenolate mofetil (MMF) or cyclophosphamide (CP) as steroid-sparing immunosuppressants. MMF was clearly preferred over CP for induction therapy of LN class III, whereas CP and MMF were equally proposed for LN class IV. MMF was most often recommended for maintenance therapy in conjunction with oral corticosteroids and continued for at least 3 years and 1 year, respectively, after remission. Hydroxychloroquine was widely accepted as a concomitant measure followed by renin-angiotensin system inhibitors in cases of arterial hypertension and/or proteinuria.<h4>Conclusion</h4>The majority of pediatric rheumatologists and nephrologists in Germany and Austria propose the use of corticosteroids, most often in combination with either MMF or CP, for treatment of proliferative LN in children. The considerable heterogeneity of responses supports the need for a treat-to-target protocol for juvenile proliferative LN between pediatric rheumatologists and nephrologists.

Item Type: Article
Uncontrolled Keywords: SLE, nephritis, T2T, mycophenolate mofetil, cyclophosphamide, corticosteroid, kidney biopsy
Divisions: Faculty of Health and Life Sciences
Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences
Depositing User: Symplectic Admin
Date Deposited: 08 Nov 2022 16:49
Last Modified: 18 Jan 2023 19:43
DOI: 10.3389/fped.2022.851998
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3166076
Dimensions
Altmetric
CORE (COnnecting REpositories)